Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
AZN
AZN
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
AZN News
AstraZeneca Acquires Global Rights to COPD Treatment TQC3721
8h ago
seekingalpha
AstraZeneca and Daiichi Sankyo Near UK Pricing Deal for Breast Cancer Drug
1h ago
seekingalpha
MindWalk Files European Patent for Biological Data Architecture Underpinning AI Drug Discovery
1d ago
PRnewswire
MindWalk Files European Patent for Biological Data Architecture Underpinning AI Drug Discovery
1d ago
Newsfilter
US Stocks Rise on Tech Bargain Hunting and Optimism for Rate Cuts
2d ago
seekingalpha
Comparative Analysis of International Stock ETFs
5d ago
NASDAQ.COM
Comparison of Core International Stock ETFs
5d ago
Fool
AstraZeneca Partners with CSPC for $1.77B Kidney Disease Treatments
6d ago
seekingalpha
Abbisko and AstraZeneca Collaborate on Novel Lung Cancer Therapy
6d ago
NASDAQ.COM
Abbisko and AstraZeneca Form Strategic Collaboration for Lung Cancer Therapy
6d ago
seekingalpha
Abbisko and AstraZeneca Form Strategic Collaboration for Lung Cancer Therapy
6d ago
PRnewswire
Abbisko and AstraZeneca Enter Strategic Collaboration for NSCLC Therapy
6d ago
Newsfilter
FDA to Announce Multiple Therapy Decisions in July
Jul 01 2026
NASDAQ.COM
AstraZeneca's Datroway Recommended for EU Approval in TNBC Treatment
Jun 29 2026
NASDAQ.COM
Enhertu Approved for Six Indications in the EU
Jun 29 2026
Newsfilter
CelLBxHealth PLC Earnings Review and Outlook
Jun 24 2026
Yahoo Finance
Show More News
